Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · IEX Real-Time Price · USD
3.325
+0.075 (2.31%)
Apr 26, 2024, 10:20 AM EDT - Market open

LIXT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Selling, General & Admin
2.73.823.752.041.672.11.341.260.751.29
Upgrade
Research & Development
0.91.351.741.220.820.040.470.872.091.12
Upgrade
Other Operating Expenses
1.51.151.230000000
Upgrade
Operating Expenses
5.096.316.723.272.492.141.812.132.852.4
Upgrade
Operating Income
-5.09-6.31-6.72-3.27-2.49-2.14-1.81-2.13-2.85-2.4
Upgrade
Interest Expense / Income
0.020.010.010000000
Upgrade
Other Expense / Income
-0.02-0.010-0.01-0.05-0-0-00.010.36
Upgrade
Pretax Income
-5.09-6.31-6.73-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
Net Income
-5.09-6.31-6.73-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
Preferred Dividends
0000000000
Upgrade
Net Income Common
-5.09-6.31-6.73-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
Shares Outstanding (Basic)
2211111111
Upgrade
Shares Outstanding (Diluted)
2211111111
Upgrade
Shares Change
21.10%17.41%19.48%0.92%14.04%5.34%16.59%2.31%5.38%6.79%
Upgrade
EPS (Basic)
-2.66-3.99-5.00-2.90-2.20-2.40-1.80-2.40-3.60-3.60
Upgrade
EPS (Diluted)
-2.66-3.99-5.00-2.90-2.20-2.40-1.80-2.40-3.60-3.60
Upgrade
Free Cash Flow
-4.29-4.61-4.14-2.13-1.67-1.51-1.41-1.68-2.18-1.64
Upgrade
Free Cash Flow Per Share
-2.24-2.92-3.08-1.89-1.50-1.54-1.52-2.10-2.80-2.21
Upgrade
EBITDA
-5.07-6.3-6.72-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
EBIT
-5.07-6.3-6.72-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).